| pubmed-article:21562374 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21562374 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:21562374 | lifeskim:mentions | umls-concept:C0038435 | lld:lifeskim |
| pubmed-article:21562374 | lifeskim:mentions | umls-concept:C0008031 | lld:lifeskim |
| pubmed-article:21562374 | lifeskim:mentions | umls-concept:C0039593 | lld:lifeskim |
| pubmed-article:21562374 | lifeskim:mentions | umls-concept:C0032743 | lld:lifeskim |
| pubmed-article:21562374 | lifeskim:mentions | umls-concept:C0442711 | lld:lifeskim |
| pubmed-article:21562374 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:21562374 | pubmed:dateCreated | 2011-5-12 | lld:pubmed |
| pubmed-article:21562374 | pubmed:abstractText | To evaluate the feasibility of dipyridamole-induced reversible ischemia on myocardial perfusion positron emission tomography (PET) imaging using Rubidium-82 (Rb-82 PET) to predict the presence of acute coronary syndrome (ACS) in emergency department (ED) chest pain patients at low risk who were admitted to an observation unit. | lld:pubmed |
| pubmed-article:21562374 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21562374 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21562374 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21562374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21562374 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21562374 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:21562374 | pubmed:issn | 1535-2811 | lld:pubmed |
| pubmed-article:21562374 | pubmed:author | pubmed-author:RossMichael... | lld:pubmed |
| pubmed-article:21562374 | pubmed:author | pubmed-author:PittsStephen... | lld:pubmed |
| pubmed-article:21562374 | pubmed:author | pubmed-author:OsborneAnwar... | lld:pubmed |
| pubmed-article:21562374 | pubmed:author | pubmed-author:MooreBrooksB | lld:pubmed |
| pubmed-article:21562374 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21562374 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:21562374 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21562374 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21562374 | pubmed:pagination | 41-3 | lld:pubmed |
| pubmed-article:21562374 | pubmed:meshHeading | pubmed-meshheading:21562374... | lld:pubmed |
| pubmed-article:21562374 | pubmed:meshHeading | pubmed-meshheading:21562374... | lld:pubmed |
| pubmed-article:21562374 | pubmed:meshHeading | pubmed-meshheading:21562374... | lld:pubmed |
| pubmed-article:21562374 | pubmed:meshHeading | pubmed-meshheading:21562374... | lld:pubmed |
| pubmed-article:21562374 | pubmed:meshHeading | pubmed-meshheading:21562374... | lld:pubmed |
| pubmed-article:21562374 | pubmed:meshHeading | pubmed-meshheading:21562374... | lld:pubmed |
| pubmed-article:21562374 | pubmed:meshHeading | pubmed-meshheading:21562374... | lld:pubmed |
| pubmed-article:21562374 | pubmed:meshHeading | pubmed-meshheading:21562374... | lld:pubmed |
| pubmed-article:21562374 | pubmed:meshHeading | pubmed-meshheading:21562374... | lld:pubmed |
| pubmed-article:21562374 | pubmed:meshHeading | pubmed-meshheading:21562374... | lld:pubmed |
| pubmed-article:21562374 | pubmed:meshHeading | pubmed-meshheading:21562374... | lld:pubmed |
| pubmed-article:21562374 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21562374 | pubmed:articleTitle | The feasibility of Rubidium-82 positron emission tomography stress testing in low-risk chest pain protocol patients. | lld:pubmed |
| pubmed-article:21562374 | pubmed:affiliation | Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA. anwaro@mac.com | lld:pubmed |
| pubmed-article:21562374 | pubmed:publicationType | Journal Article | lld:pubmed |
